Document is current
Any future updates will be listed below
-
Authors
Hoffman, Kim A. http://orcid.org/0000-0003-3063-7881
Baker, Robin
Fanucchi, Laura C.
Lum, Paula J.
Kunkel, Lynn E.
Ponce Terashima, Javier
McCarty, Dennis
Jacobs, Petra
Korthuis, P. Todd
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03275350 at ClinicalTrials.govDocuments that mention this clinical trial
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
https://doi.org/10.1186/s13722-021-00277-z
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (UG1 DA015815)
- License Information
-
More Information
Article History
Received: 3 May 2021
Accepted: 1 November 2021
First Online: 10 November 2021
Declarations
:
: The Advarra Institutional Review Board reviewed the study protocol, qualitative interview guides, and information sheet.
: Not applicable.
: Alkermes (a global biopharmaceutical company) donated the extended-release naltrexone used in the study protocol. The authors report no additional competing interests.
